Notch signaling and inherited disease syndromes

Human Molecular Genetics

Volumn 12, Issue REV. ISS. 1, 2003, Pages

  Gridley, Thomas ^a  

^a JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NOTCH RECEPTOR;

ALAGILLE SYNDROME; ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOSOMAL DOMINANT DISORDER; BRAIN INFARCTION; CEREBRAL ARTERY DISEASE; CONTROLLED STUDY; GENE DELETION; GENETIC CODE; HETEROZYGOSITY; JARCHO LEVIN SYNDROME; LEUKOENCEPHALOPATHY; MISSENSE MUTATION; MOUSE; NONHUMAN; PATHOLOGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SPONTANEOUS MUTATION;

ALAGILLE SYNDROME; ANIMALS; DEMENTIA, MULTI-INFARCT; DYSOSTOSES; HUMANS; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; MUTATION; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION;

ANIMALIA; ECHINODERMATA; HEXAPODA; MAMMALIA; NEMATODA;

EID: 0037390535     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Aster, J.C. and Pear, W.S. (2001) Notch signaling in leukemia. Curr. Opin. Hematol., 8, 237-244.
2. Artavanis-Tsakonas, S., Rand, M.D. and Lake, R.J. (1999) Notch signaling: cell fate control and signal integration in development. Science, 284, 770-776.
3. Kadesch, T. (2000) Notch signaling: a dance of proteins changing partners. Exp. Cell Res., 260, 1-8.
4. Mumm, J.S. and Kopan, R. (2000) Notch signaling: from the outside in. Dev. Biol., 228, 151-165.
5. Weinmaster, G. (2000) Notch signal transduction: a real Rip and more. Curr. Opin. Genet. Dev., 10, 363-369.
6. Allman, D., Punt, J.A., Izon, D.J., Aster, J.C. and Pear, W.S. (2002) An invitation to T and more: notch signaling in lymphopoiesis. Cell, 109, S1-S11.
7. Baron, M., Aslam, H., Flasza, M., Fostier, M., Higgs, J.E., Mazaleyrat, S.L. and Wilkin, M.B. (2002) Multiple levels of Notch signal regulation. Mol. Membr. Biol., 19, 27-38.
8. Kopan, R. (2002) Notch: a membrane-bound transcription factor. J. Cell Sci., 115, 1095-1097.
9. Krantz, I.D., Piccoli, D.A. and Spinner, N.B. (1997) Alagille syndrome. J. Med. Genet., 34, 152-157.
10. Krantz, I.D. (2002) Alagille syndrome: chipping away at the tip of the iceberg. Am. J. Med. Genet., 112, 160-162.
11. Emerick, K.M., Rand, E.B., Goldmuntz, E., Krantz, I.D., Spinner, N.B. and Piccoli, D.A. (1999) Features of Alagille syndrome in 92 patients: frequency and relation to prognosis. Hepatology, 29, 822-829.
12. Krantz, I.D., Smith, R., Colliton, R.P., Tinkel, H., Zackai, E.H., Piccoli, D.A., Goldmuntz, E. and Spinner, N.B. (1999) Jagged1 mutations in patients ascertained with isolated congenital heart defects. Am. J. Med. Genet., 84, 56-60.
13. Eldadah, Z.A., Hamosh, A., Biery, N.J., Montgomery, R.A., Duke, M., Elkins, R. and Dietz, H.C. (2001) Familial Tetralogy of Fallot caused by mutation in the jagged1 gene. Hum. Mol. Genet., 10, 163-169.
14. McElhinney, D.B., Krantz, I.D., Bason, L., Piccoli, D.A., Emerick, K.M., Spinner, N.B. and Goldmuntz, E. (2002) Analysis of cardiovascular phenotype and genotype-phenotype correlation in individuals with a JAG1 mutation and/or Alagille syndrome. Circulation, 106, 2567-2574.
15. Kamath, B.M., Stolle, C., Bason, L., Colliton, R.P., Piccoli, D.A., Spinner, N.B. and Krantz, I.D. (2002) Craniosynostosis in Alagille syndrome. Am. J. Med. Genet., 112, 176-180.
16. Kamath, B.M., Loomes, K.M., Oakey, R.J. and Krantz, I.D. (2002) Supernumerary digital flexion creases: an additional clinical manifestation of Alagille syndrome. Am. J. Med. Genet., 112, 171-175.
17. Li, L., Krantz, I.D., Deng, Y., Genin, A., Banta, A.B., Collins, C.C., Qi, M., Trask, B.J., Kuo, W.L., Cochran, J. et al. (1997) Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat. Genet., 16, 243-251.
18. Oda, T., Elkahloun, A.G., Pike, B.L., Okajima, K., Krantz, I.D., Genin, A., Piccoli, D.A., Meltzer, P.S., Spinner, N.B., Collins, F.S. et al. (1997) Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat. Genet., 16, 235-242.
19. Spinner, N.B., Colliton, R.P., Crosnier, C., Krantz, I.D., Hadchouel, M. and Meunier-Rotival, M. (2001) Jagged1 mutations in Alagille syndrome. Hum. Mutat., 17, 18-33.
20. Morrissette, J.J.D., Colliton, R.P. and Spinner, N.B. (2001) Defective intracellular transport and processing of JAG1 missense mutations in Alagille syndrome. Hum. Mol. Genet., 10, 405-413.
21. Kamath, B.M., Krantz, I.D., Spinner, N.B., Heubi, J.E. and Piccoli, D.A. (2002) Monozygotic twins with a severe form of Alagille syndrome and phenotypic discordance. Am. J. Med. Genet., 112, 194-197.
22. Krantz, I.D., Smith, R., Colliton, R.P., Goldmuntz, E., Zackai, E.H., Piccoli, D.A. and Spinner, N.B. (1999) The phenotypic implication of having a Jagged1 mutation: not just Alagille syndrome anymore. Proc. Greenwood Genet. Center, 18, 80-81.
23. Le Caignec, C., Lefevre, M., Schott, J.J., Chaventre, A., Gayet, M., Calais, C. and Moisan, J.P. (2002) Familial deafness, congenital heart defects, and posterior embryotoxon caused by cysteine substitution in the first epidermal-growth-factor-like domain of jagged1. Am. J. Hum. Genet., 71, 180-186.
24. Tsai, H., Hardisty, R.E., Rhodes, C., Kiernan, A.E., Roby, P., Tymowska-Lalanne, Z., Mburu, P., Rastan, S., Hunter, A.J., Brown, S.D. et al. (2001) The mouse slalom mutant demonstrates a role for Jagged1 in neuroepithelial patterning in the organ of Corti. Hum. Mol. Genet., 10, 507-512.
25. Kiernan, A.E., Ahituv, N., Fuchs, H., Balling, R., Avraham, K.B., Steel, K.P. and Hrabe de Angelis, M. (2001) The Notch ligand Jagged1 is required for inner ear sensory development. Proc. Natl Acad. Sci. USA, 98, 3873-3878.
26. Xue, Y., Gan, X., Lindsell, C.E., Norton, C.R., Chang, B., Hicks, C., Gendron-Maguire, M., Rand, E.B., Weinmaster, G. and Gridley, T. (1999) Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum. Mol. Genet., 8, 723-730.
27. McCright, B., Gao, X., Shen, L., Lozier, J., Lan, Y., Maguire, M., Herzlinger, D., Weinmaster, G., Jiang, R. and Gridley, T. (2001) Defects in development of the kidney, heart and eye vasculature in mice homozygous for a hypomorphic Notch2 mutation. Development, 128, 491-502.
28. McCright, B., Lozier, J. and Gridley, T. (2002) A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency. Development, 129, 1075-1082.
29. Nakagawa, O., McFadden, D.G., Nakagawa, M., Yanagisawa, H., Hu, T., Srivastava, D. and Olson, E.N. (2000) Members of the HRT family of basic helix-loop-helix proteins act as transcriptional repressors downstream of notch signaling. Proc. Natl Acad. Sci. USA, 97, 13655-13660.
30. Iso, T., Chung, G., Hamamori, Y. and Kedes, L. (2002) HERP1 is a cell type-specific primary target of Notch. J. Biol. Chem., 277, 6598-6607.
31. -/- mice. Curr. Biol., 12, 1601-1604.
32. Donovan, J., Kordylewska, A., Jan, Y.N. and Utset, M.F. (2002) Tetralogy of fallot and other congenital heart defects in Hcy2 mutant mice. Curr. Biol., 12, 1605-1610.
33. Mortier, G.R., Lachman, R.S., Bocian, M. and Rimoin, D.L. (1996) Multiple vertebral segmentation defects: analysis of 26 new patients and review of the literature. Am. J. Med. Genet., 61, 310-319.
34. Turnpenny, P.D., Bulman, M.P., Frayling, T.M., Abu-Nasra, T.K., Garrett, C., Hattersley, A.T. and Ellard, S. (1999) A gene for autosomal recessive spondylocostal dysostosis maps to 19q13.1-q13.3. Am. J. Hum. Genet., 65, 175-182.
35. Bulman, M.P., Kusumi, K., Frayling, T.M., McKeown, C., Garrett, C., Lander, E.S., Krumlauf, R., Hattersley, A.T., Ellard, S. and Turnpenny, P.D. (2000) Mutations in the human delta homologue, DLL3, cause axial skeletal defects in spondylocostal dysostosis. Nat. Genet., 24, 438-441.
36. Kusumi, K., Sun, E., Kerrebrock, A.W, Bronson, R.T., Chi, D.-C., Bulotsky, M.S., Spencer, J.B., Birren, B.W, Frankel, W.N. and Lander, E.S. (1998) The mouse pudgy mutation disrupts Delta homologue D113 and initiation of early somite boundaries. Nat. Genet., 19, 274-278.
37. Dunwoodie, S.L., Clements, M., Sparrow, D.B., Sa, X., Conlon, R.A. and Beddington, R.S. (2002) Axial skeletal defects caused by mutation in the spondylocostal dysplasia/pudgy gene D113 are associated with disruption of the segmentation clock within the presomitic mesoderm. Development, 129, 1795-1806.
38. Maroto, M. and Pourquié, O. (2001) A molecular clock involved in somite segmentation. Curr. Top. Dev. Biol., 51, 221-248.
39. Zhang, N., Norton, C.R. and Gridley, T. (2002) Segmentation defects of Notch pathway mutants and absence of a synergistic phenotype in Lunatic fringe/Radical fringe double mutant mice. Genesis, 33, 21-28.
40. Iughetti, P., Alonso, L.G., Wilcox, W., Alonso, N. and Passos-Bueno, M.R. (2000) Mapping of the autosomal recessive (AR) craniometaphyseal dysplasia locus to chromosome region 6q21-22 and confirmation of genetic heterogeneity for mild AR spondylocostal dysplasia. Am. J. Med. Genet., 95, 482-491.
41. Bruckner, K., Perez, L., Clausen, H. and Cohen, S. (2000) Glycosyltransferase activity of Fringe modulates Notch-Delta interactions. Nature, 406, 411-415.
42. Moloney, D.J., Panin, V.M., Johnston, S.H., Chen, J., Shao, L., Wilson, R., Wang, Y., Stanley, P., Irvine, K.D., Haltiwanger, R.S. et al. (2000) Fringe is a glycosyltransferase that modifies Notch. Nature, 406, 369-375.
43. Evrard, Y.A., Lun, Y., Aulehla, A., Gan, L. and Johnson, R.L. (1998) Lunatic fringe is an essential mediator of somite segmentation and patterning. Nature, 394, 377-381.
44. Zhang, N. and Gridley, T (1998) Defects in somite formation in Lunatic fringe deficient mice. Nature, 394, 374-377.
45. Tournier-Lasserve, E., Joutel, A., Melki, J., Weissenbach, J., Lathrop, G.M., Chabriat, H., Mas, J.L., Cabanis, E.A., Baudrimont, M., Maciazek, J. et al. (1993) Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat. Genet., 3, 256-259.
46. Chabriat, H., Vahedi, K., Iba-Zizen, M.T., Joutel, A., Nibbio, A., Nagy, T.G., Krebs, M.O., Julien, J., Dubois, B., Ducrocq, X. et al. (1995) Clinical spectrum of CADASIL: a study of 7 families. Lancet, 346, 934-939.
47. Ruchoux, M.M., Guerouaou, D., Vandenhaute, B., Pruvo, J.P., Vermersch, P. and Leys, D. (1995) Systemic vascular smooth muscle cell impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Acta Neuropathol. (Berl.), 89, 500-512.
48. Ebke, M., Dichgans, M., Bergmann, M., Voelter, H.U., Rieger, P., Gasser, T. and Schwendemann, G. (1997) CADASIL: skin biopsy allows diagnosis in early stages. Acta Neurol. Scand., 95, 351-357.
49. Mayer, M., Straube, A., Bruening, R., Uttner, I., Pongratz, D., Gasser, T., Dichgans, M. and Muller-Hocker, J. (1999) Muscle and skin biopsies are a sensitive diagnostic tool in the diagnosis of CADASIL. J. Neurol., 246, 526-532.
50. Ruchoux, M.M., Brulin, P., Leteurtre, E. and Maurage, C.A. (2000) Skin biopsy value and leukoaraiosis. Ann. NY Acad. Sci., 903, 285-292.
51. Joutel, A., Favrole, P., Labauge, P., Chabriat, H., Lescoat, C., Andreux, F., Domenga, V., Cecillon, M., Vahedi, K., Ducros, A. et al. (2001) Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis. Lancet, 358, 2049-2051.
52. Joutel, A., Corpechot, C., Ducros, A., Vahedi, K., Chabriat, H., Mouton, P., Alamowitch, S., Domenga, V., Cécillion, M., Maréchal, E. et al. (1996) Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature, 383, 707-710.
53. Joutel, A., Vahedi, K., Corpechot, C., Troesch, A., Chabriat, H., Vayssiere, C., Cruaud, C., Maciazek, J., Weissenbach, J., Bousser, M.G. et al. (1997) Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet, 350, 1511-1515.
54. Joutel, A., Chabriat, H., Vahedi, K., Domenga, V., Vayssiere, C., Ruchoux, M.M., Lucas, C., Leys, D., Bousser, M.G. and Tournier-Lasserve, E. (2000) Splice site mutation causing a seven amino acid Notch3 in-frame deletion in CADASIL. Neurology, 54, 1874-1875.
55. Dichgans, M., Herzog, J. and Gasser, T. (2001) NOTCH3 mutation involving three cysteine residues in a family with typical CADASIL. Neurology, 57, 1714-1717.
56. Campbell, I.D. and Bork, P. (1993) Epidermal growth factor-like module. Curr. Opin. Struct. Biol., 3, 385-392.
57. Haritunians, T., Boulter, J., Hicks, C., Buhrman, J., DiSibio, G., Shawber, C., Weinmaster, G., Nofziger, D. and Schanen, C. (2002) CADASIL Notch3 mutant proteins localize to the cell surface and bind ligand. Circ. Res., 90, 506-508.
58. Joutel, A., Andreux, E, Gaulis, S., Domenga, V., Cecillon, M., Battail, N., Piga, N., Chapon, F., Godfrain, C. and Tournier-Lasserve, E. (2000) The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J. Clin. Invest., 105, 597-605.
59. Leimeister, C., Schumacher, N., Steidl, C. and Gessler, M. (2000) Analysis of HeyL expression in wild-type and Notch pathway mutant mouse embryos. Mech. Dev., 98, 175-178.
60. Villa, N., Walker, L., Lindsell, C.E., Gasson, J., Iruela-Arispe, M.L. and Weinmaster, G. (2001) Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. Mech. Dev., 108, 161-164.
61. Prakash, N., Hansson, E., Betsholtz, C., Mitsiadis, T. and Lendahl, U. (2002) Mouse Notch 3 expression in the pre- and postnatal brain: relationship to the stroke and dementia syndrome CADASIL. Exp. Cell Res., 278, 31-44.
62. Ruchoux, M.M., Domenga, V., Bruin, P., Maciazek, J., Limol, S., Tournier-Lasserve, E. and Joutel, A. (2003) Transgenic mice expressing mutant Notch3 develop vascular alterations characteristic of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Am. J. Pathol., 162, 329-342.